Stable Isotope Labelled Ublituximab Biosimilar – Anti-MS4A1/CD20 mAb – Research Grade

Reference: PX-TA1264-SIL-1MG
Size

Brand

Product type

Clonality

Expression system

Applications

Product nameStable Isotope Labelled Ublituximab Biosimilar - Anti-MS4A1/CD20 mAb - Research Grade
SourceCAS 1174014-05-1
SpeciesChimeric
Expression systemMammalian cells
Purity>95%
BufferPBS buffer PH7.5
Delivery conditionBlue Ice
Delivery Time3-5 days if in stock; 5-8 weeks if production needed
Storage conditionstore at -80°C
BrandProteoGenix
ApplicationsMS
Aliases /SynonymsLFB-R603, TG-1101,TGTX-1101
ReferencePX-TA1264-SIL
Related ProductsPX-P3060
NoteFor research use only. Not suitable for clinical or therapeutic use.
IsotypeIgG1-kappa
ClonalityMonoclonal Antibody
FormatLyophilized
LabellingArginine: 13C6,15N4 ; Lysine: 13C6,15N2, >99%
Isotopic Enrichment99%
Stability1 year

General information on Anti-MS4A1/CD20[Homo sapiens] (Ublituximab) Monoclonal Antibody

Ublituximab has been investigated for the treatment of B-cell Lymphoma, Neuromyelitis Optica, Mantle Cell Lymphoma, Non-Hodgkins Lymphoma, and Marginal Zone Lymphoma.

Reviews

There are no reviews yet.

REVIEW YOUR PRODUCT

Be the first to review “Stable Isotope Labelled Ublituximab Biosimilar – Anti-MS4A1/CD20 mAb – Research Grade”

Your email address will not be published. Required fields are marked *

Contact us

Send us a message from the form below







    Cart (0 Items)

    Your cart is currently empty.

    View Products